Jing Cai

3.9k total citations · 2 hit papers
62 papers, 2.6k citations indexed

About

Jing Cai is a scholar working on Molecular Biology, Genetics and Oncology. According to data from OpenAlex, Jing Cai has authored 62 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Molecular Biology, 26 papers in Genetics and 17 papers in Oncology. Recurrent topics in Jing Cai's work include Virus-based gene therapy research (24 papers), CAR-T cell therapy research (13 papers) and Animal Virus Infections Studies (7 papers). Jing Cai is often cited by papers focused on Virus-based gene therapy research (24 papers), CAR-T cell therapy research (13 papers) and Animal Virus Infections Studies (7 papers). Jing Cai collaborates with scholars based in China, United States and Japan. Jing Cai's co-authors include Duojia Pan, Yonggang Zheng, Nailing Zhang, Robert A. Anders, Anirban Maitra, Karen K David, Roeland F. de Wilde, Jixin Dong, Pentao Liu and Marco Giovannini and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and Nature Communications.

In The Last Decade

Jing Cai

57 papers receiving 2.6k citations

Hit Papers

The Merlin/NF2 Tumor Suppressor Functions through the YAP... 2010 2026 2015 2020 2010 2022 200 400 600

Peers

Jing Cai
Utpal P. Davé United States
Tania Maffucci United Kingdom
Julio C. Valencia United States
Dean Yimlamai United States
Richard N. Sifers United States
Utpal P. Davé United States
Jing Cai
Citations per year, relative to Jing Cai Jing Cai (= 1×) peers Utpal P. Davé

Countries citing papers authored by Jing Cai

Since Specialization
Citations

This map shows the geographic impact of Jing Cai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jing Cai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jing Cai more than expected).

Fields of papers citing papers by Jing Cai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jing Cai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jing Cai. The network helps show where Jing Cai may publish in the future.

Co-authorship network of co-authors of Jing Cai

This figure shows the co-authorship network connecting the top 25 collaborators of Jing Cai. A scholar is included among the top collaborators of Jing Cai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jing Cai. Jing Cai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cai, Jing, Jun Zhang, Kai Wang, et al.. (2025). Evaluating the long-term effects of combination antiretroviral therapy of HIV infection: a modeling study. Journal of Mathematical Biology. 90(4). 36–36.
3.
Min, Xiang Jia, Wei Jiang, Hengxu Mao, et al.. (2025). Pyridoxal phosphate inhibits alpha-synuclein-induced ferroptosis by activating GOT1 to enhance the methionine salvage pathway in Parkinson's disease. Experimental Neurology. 393. 115411–115411. 1 indexed citations
4.
Wang, Liqiu, Mengqiu Li, Guang‐Yu Lian, et al.. (2024). Palmitoylation acts as a checkpoint for MAVS aggregation to promote antiviral innate immune responses. Journal of Clinical Investigation. 134(23). 6 indexed citations
6.
Chen, Xiaoyu, Ying Liu, Wenbo Zhu, et al.. (2024). Arming oncolytic M1 virus with gasdermin E enhances antitumor efficacy in breast cancer. iScience. 27(11). 111148–111148. 4 indexed citations
7.
Cai, Jing, Yue Wang, Xinfa Wang, et al.. (2023). AMPK attenuates SHH subgroup medulloblastoma growth and metastasis by inhibiting NF-κB activation. Cell & Bioscience. 13(1). 15–15. 11 indexed citations
8.
Jia, Xudong, Yuanzhu Gao, Dan Jia, et al.. (2023). STT3A-mediated viral N-glycosylation underlies the tumor selectivity of oncolytic virus M1. Oncogene. 42(48). 3575–3588.
9.
Liu, Yang, Xiaoting Xiao, Yinting Chen, et al.. (2022). Overcoming resistance to oncolytic virus M1 by targeting PI3K-γ in tumor-associated myeloid cells. Molecular Therapy. 30(12). 3677–3693. 5 indexed citations
10.
Sun, Shuxin, Yang Liu, Chaobin He, et al.. (2021). Combining NanoKnife with M1 oncolytic virus enhances anticancer activity in pancreatic cancer. Cancer Letters. 502. 9–24. 36 indexed citations
11.
Pu, Xiaohong, Qing Ye, Jing Cai, et al.. (2021). Typing FGFR2 translocation determines the response to targeted therapy of intrahepatic cholangiocarcinomas. Cell Death and Disease. 12(3). 256–256. 20 indexed citations
12.
X, Li, Jianping Zhao, Haoran Zhang, & Jing Cai. (2020). Silencing of LncRNA Metastasis-Associated Lung Adenocarcinoma Transcript 1 Inhibits the Proliferation and Promotes the Apoptosis of Gastric Cancer Cells Through Regulating microRNA-22-3p-Mediated ErbB3. SHILAP Revista de lepidopterología. 2 indexed citations
13.
Cai, Jing, et al.. (2020). Protein phosphatase 4 promotes Hedgehog signaling through dephosphorylation of Suppressor of fused. Cell Death and Disease. 11(8). 686–686. 9 indexed citations
14.
Cai, Jing, Wenbo Zhu, Yuan Lin, et al.. (2020). Systematic Characterization of the Biodistribution of the Oncolytic Virus M1. Human Gene Therapy. 31(21-22). 1203–1213. 18 indexed citations
15.
Cai, Jing & Guangmei Yan. (2020). The Identification and Development of a Novel Oncolytic Virus: Alphavirus M1. Human Gene Therapy. 32(3-4). 138–149. 14 indexed citations
16.
Cai, Jing, Wenbo Zhu, Yuan Lin, et al.. (2020). Lonidamine potentiates the oncolytic efficiency of M1 virus independent of hexokinase 2 but via inhibition of antiviral immunity. Cancer Cell International. 20(1). 532–532. 7 indexed citations
17.
Liu, Ying, Ke Li, Wenbo Zhu, et al.. (2020). Suppression of CCDC6 sensitizes tumor to oncolytic virus M1. Neoplasia. 23(1). 158–168. 11 indexed citations
18.
Cai, Jing, Xuewen Song, Wei Wang, et al.. (2018). A RhoA–YAP–c-Myc signaling axis promotes the development of polycystic kidney disease. Genes & Development. 32(11-12). 781–793. 95 indexed citations
19.
Zhang, Haipeng, Kai Li, Yuan Lin, et al.. (2017). Targeting VCP enhances anticancer activity of oncolytic virus M1 in hepatocellular carcinoma. Science Translational Medicine. 9(404). 53 indexed citations
20.
Lin, Herbert Y., Patricia A. Masso‐Welch, Y. Peter Di, et al.. (1993). The 170-kDa glucose-regulated stress protein is an endoplasmic reticulum protein that binds immunoglobulin.. Molecular Biology of the Cell. 4(11). 1109–1119. 138 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026